Bio-Rad Laboratories Inc (BIO)
350.23
-12.97
(-3.57%)
USD |
NYSE |
Nov 14, 16:00
351.79
+1.56
(+0.45%)
Pre-Market: 07:00
Bio-Rad Laboratories Free Cash Flow: 223.75M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 223.75M |
| June 30, 2024 | 177.42M |
| March 31, 2024 | 185.48M |
| December 31, 2023 | 218.26M |
| September 30, 2023 | 222.95M |
| June 30, 2023 | 152.76M |
| March 31, 2023 | 125.27M |
| December 31, 2022 | 80.29M |
| September 30, 2022 | 151.49M |
| June 30, 2022 | 363.77M |
| March 31, 2022 | 459.07M |
| December 31, 2021 | 535.72M |
| September 30, 2021 | 666.63M |
| June 30, 2021 | 586.58M |
| March 31, 2021 | 529.35M |
| December 31, 2020 | 476.41M |
| September 30, 2020 | 369.01M |
| June 30, 2020 | 321.99M |
| March 31, 2020 | 381.17M |
| December 31, 2019 | 359.36M |
| September 30, 2019 | 272.30M |
| June 30, 2019 | 243.86M |
| March 31, 2019 | 161.82M |
| December 31, 2018 | 155.67M |
| September 30, 2018 | 147.82M |
| Date | Value |
|---|---|
| June 30, 2018 | 115.89M |
| March 31, 2018 | 97.71M |
| December 31, 2017 | -10.99M |
| September 30, 2017 | -4.772M |
| June 30, 2017 | -0.915M |
| March 31, 2017 | 11.70M |
| December 31, 2016 | 74.50M |
| September 30, 2016 | 32.95M |
| June 30, 2016 | 78.28M |
| March 31, 2016 | 39.04M |
| December 31, 2015 | 72.84M |
| September 30, 2015 | 64.96M |
| June 30, 2015 | 70.67M |
| March 31, 2015 | 107.26M |
| December 31, 2014 | 136.83M |
| September 30, 2014 | 179.37M |
| June 30, 2014 | 150.67M |
| March 31, 2014 | 102.96M |
| December 31, 2013 | 61.78M |
| September 30, 2013 | 74.82M |
| June 30, 2013 | 74.52M |
| March 31, 2013 | 110.92M |
| December 31, 2012 | 121.83M |
| September 30, 2012 | 112.00M |
| June 30, 2012 | 104.00M |
Free Cash Flow Range, Past 5 Years
80.29M
Minimum
Dec 2022
666.63M
Maximum
Sep 2021
329.34M
Average
340.68M
Median
Free Cash Flow Benchmarks
| Agilent Technologies Inc | 1.417B |
| Bruker Corp | 156.70M |
| Azenta Inc | 40.93M |
| Harvard Bioscience Inc | 0.16M |
| Bionano Genomics Inc | -106.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 163.61M |
| Cash from Investing (Quarterly) | -55.64M |
| Cash from Financing (Quarterly) | -95.99M |
| Free Cash Flow Per Share (Quarterly) | 3.572 |
| Free Cash Flow to Equity (Quarterly) | 88.91M |
| Free Cash Flow to Firm (Quarterly) | 99.97M |
| Free Cash Flow Yield | 2.25% |